{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-016401","form_type":"8-K","ticker":"PRVA","cik":"0001759655","company_name":"Privia Health Group, Inc.","filed_at":"2023-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.424649+00:00","generated_at":"2026-06-15T13:51:35.125078+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Privia Health selling stockholders offer 42.56M shares; company receives no proceeds","bullets":["Underwriting agreement with Goldman Sachs for secondary offering of 42,561,196 shares of common stock.","Offering closed May 8, 2023; company received no proceeds from sale by selling stockholders.","Registration statement on Form S-3ASR (File No. 333-268394) filed November 15, 2022, with prospectus supplement.","Total estimated expenses of $595,185 for the issuance to be paid by the company."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-016401","json":"https://secwatch.observer/filing/0001628280-23-016401.json","markdown":"https://secwatch.observer/filing/0001628280-23-016401.md","text":"https://secwatch.observer/filing/0001628280-23-016401.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759655/000162828023016401/0001628280-23-016401-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759655/000162828023016401/prva-20230504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T13:51:35.125078+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"efca89adfdf32700113bf1432ab33ffb13238b3a","claim":"Privia Health Group, Inc. entered into Underwriting Agreement with Goldman Sachs & Co. LLC (effective 2023-05-04).","evidence_excerpt":"On May 4, 2023, Privia Health Group, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC as underwriter (the “Underwriter”) and the selling stockholders listed on Schedule I thereto (the “Selling Stockholders”) with respect to an underwritten offering by the Selling Stockholders of 42,561,196 shares (the “Shares”) of the Company’s common stock, par value $0.01 per share, held by such Selling Stockholders.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1759655/000162828023016401/0001628280-23-016401-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Goldman Sachs & Co. LLC"},{"label":"Effective","value":"2023-05-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}